Ayala Pharmaceuticals AYLA

$ 0.5 0.0%

Annual report 2022
added 03-31-2023

Ayala Pharmaceuticals Financial Statements 2011-2024 | AYLA

Annual Financial Statements Ayala Pharmaceuticals

	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	7.72 M	81.8 M	165 M	-	-	-	-	-	-	-	-	-
Shares	15.4 M	14.4 M	12.7 M	-	-	-	-	-	-	-	-	-
Historical Prices	0.5	5.68	13	-	-	-	-	-	-	-	-	-
Net Income	-38 M	-40.3 M	-30.1 M	-17.8 M	-8.87 M	-	-	-	-	-	-	-
Revenue	692 K	3.51 M	3.71 M	2.33 M	-	-	-	-	-	-	-	-
Cost of Revenue	602 K	3.51 M	3.71 M	1.28 M	-	-	-	-	-	-	-	-
Gross Profit	90 K	-	-	1.05 M	-	-	-	-	-	-	-	-
Operating Income	-37.5 M	-39.2 M	-29.8 M	-17.7 M	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-37.3 M	-39 M	-29.6 M	-17.6 M	-8.99 M	-	-	-	-	-	-	-
Operating Expenses	-	-	29.8 M	18.8 M	-	-	-	-	-	-	-	-
General and Administrative Expenses	1.53 M	1.59 M	7.37 M	4.34 M	3.29 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Ayala Pharmaceuticals

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	-	15.5 M	15.3 M	15.3 M	14 M	14.5 M	14.4 M	12.9 M	12.7 M	12.7 M	9.02 M	5 M	5 M	4.97 M	4.97 M	4.96 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-	-10.2 M	-8.21 M	-10 M	-	-9.8 M	-10.8 M	-9.57 M	-	-7.44 M	-6.71 M	-6.6 M	-	-5.05 M	-3.78 M	-3.54 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	91 K	38 K	458 K	-	625 K	761 K	974 K	-	658 K	1.04 M	1 M	-	845 K	852 K	265 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	91 K	38 K	368 K	-	625 K	761 K	974 K	-	658 K	1.04 M	1 M	-	485 K	160 K	265 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	90 K	90 K	90 K	-	-	-	-	-	-	-	-	-	360 K	692 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-	-10.1 M	-7.84 M	-9.85 M	-	-9.57 M	-10.7 M	-9.23 M	-	-7.28 M	-6.61 M	-6.44 M	-	-4.96 M	-3.77 M	-3.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	63 K	16 K	5 K	-	-	7 K	3 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-9.96 M	-7.76 M	-9.82 M	-	-9.43 M	-10.6 M	-9.06 M	-	-7.14 M	-6.52 M	-6.39 M	-	-4.91 M	-3.74 M	-3.58 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	-	-	9.94 M	-	-	-	9.23 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	-	2.88 M	2.26 M	2.44 M	-	2.2 M	2.54 M	2.3 M	-	1.86 M	1.55 M	1.31 M	-	945 K	1.02 M	848 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency